Antibodies in Oncology Market - Global Outlook and Forecast 2021-2027
Report Code: KNJ687425 No. of Pages: 90 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Antibodies in Oncology in Global, including the following market information: Global Antibodies in Oncology Market Revenue, 2016-2021, 2022-2027, ($ millions) Global top five companies in 2020 (%) The global Antibodies in Oncology market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibodies in Oncology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Antibodies in Oncology Market, By Type, 2016-2021, 2022-2027 ($ millions) Global Antibodies in Oncology Market Segment Percentages, By Type, 2020 (%) Murine Antibodies Chimeric and Humanised Antibodies Fully Humanized Antibodies Others China Antibodies in Oncology Market, By Application, 2016-2021, 2022-2027 ($ millions) China Antibodies in Oncology Market Segment Percentages, By Application, 2020 (%) Hospitals Academic Institutes Clinics Global Antibodies in Oncology Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) Global Antibodies in Oncology Market Segment Percentages, By Region and Country, 2020 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Total Antibodies in Oncology Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions) Total Antibodies in Oncology Market Competitors Revenues Share in Global, by Players 2020 (%) Further, the report presents profiles of competitors in the market, including the following: Novartis International AG GlaxoSmithKline plc Biogen Idec Inc. Bristol Myers Squibb Co. AstraZeneca plc. Celltrion 3SBIO Celgen Biopharma Dr Reddy’s
1 Introduction to Research & Analysis Reports
1.1 Antibodies in Oncology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antibodies in Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antibodies in Oncology Overall Market Size
2.1 Global Antibodies in Oncology Market Size: 2021 VS 2027
2.2 Global Antibodies in Oncology Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antibodies in Oncology Players in Global Market
3.2 Top Global Antibodies in Oncology Companies Ranked by Revenue
3.3 Global Antibodies in Oncology Revenue by Companies
3.4 Top 3 and Top 5 Antibodies in Oncology Companies in Global Market, by Revenue in 2020
3.5 Global Companies Antibodies in Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antibodies in Oncology Players in Global Market
3.6.1 List of Global Tier 1 Antibodies in Oncology Companies
3.6.2 List of Global Tier 2 and Tier 3 Antibodies in Oncology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antibodies in Oncology Market Size Markets, 2021 & 2027
4.1.2 Murine Antibodies
4.1.3 Chimeric and Humanised Antibodies
4.1.4 Fully Humanized Antibodies
4.1.5 Others
4.2 By Type - Global Antibodies in Oncology Revenue & Forecasts
4.2.1 By Type - Global Antibodies in Oncology Revenue, 2016-2021
4.2.2 By Type - Global Antibodies in Oncology Revenue, 2022-2027
4.2.3 By Type - Global Antibodies in Oncology Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antibodies in Oncology Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Academic Institutes
5.1.4 Clinics
5.2 By Application - Global Antibodies in Oncology Revenue & Forecasts
5.2.1 By Application - Global Antibodies in Oncology Revenue, 2016-2021
5.2.2 By Application - Global Antibodies in Oncology Revenue, 2022-2027
5.2.3 By Application - Global Antibodies in Oncology Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Antibodies in Oncology Market Size, 2021 & 2027
6.2 By Region - Global Antibodies in Oncology Revenue & Forecasts
6.2.1 By Region - Global Antibodies in Oncology Revenue, 2016-2021
6.2.2 By Region - Global Antibodies in Oncology Revenue, 2022-2027
6.2.3 By Region - Global Antibodies in Oncology Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Antibodies in Oncology Revenue, 2016-2027
6.3.2 US Antibodies in Oncology Market Size, 2016-2027
6.3.3 Canada Antibodies in Oncology Market Size, 2016-2027
6.3.4 Mexico Antibodies in Oncology Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Antibodies in Oncology Revenue, 2016-2027
6.4.2 Germany Antibodies in Oncology Market Size, 2016-2027
6.4.3 France Antibodies in Oncology Market Size, 2016-2027
6.4.4 U.K. Antibodies in Oncology Market Size, 2016-2027
6.4.5 Italy Antibodies in Oncology Market Size, 2016-2027
6.4.6 Russia Antibodies in Oncology Market Size, 2016-2027
6.4.7 Nordic Countries Antibodies in Oncology Market Size, 2016-2027
6.4.8 Benelux Antibodies in Oncology Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Antibodies in Oncology Revenue, 2016-2027
6.5.2 China Antibodies in Oncology Market Size, 2016-2027
6.5.3 Japan Antibodies in Oncology Market Size, 2016-2027
6.5.4 South Korea Antibodies in Oncology Market Size, 2016-2027
6.5.5 Southeast Asia Antibodies in Oncology Market Size, 2016-2027
6.5.6 India Antibodies in Oncology Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Antibodies in Oncology Revenue, 2016-2027
6.6.2 Brazil Antibodies in Oncology Market Size, 2016-2027
6.6.3 Argentina Antibodies in Oncology Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antibodies in Oncology Revenue, 2016-2027
6.7.2 Turkey Antibodies in Oncology Market Size, 2016-2027
6.7.3 Israel Antibodies in Oncology Market Size, 2016-2027
6.7.4 Saudi Arabia Antibodies in Oncology Market Size, 2016-2027
6.7.5 UAE Antibodies in Oncology Market Size, 2016-2027
7 Players Profiles
7.1 Novartis International AG
7.1.1 Novartis International AG Corporate Summary
7.1.2 Novartis International AG Business Overview
7.1.3 Novartis International AG Antibodies in Oncology Major Product Offerings
7.1.4 Novartis International AG Antibodies in Oncology Revenue in Global (2016-2021)
7.1.5 Novartis International AG Key News
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Corporate Summary
7.2.2 GlaxoSmithKline plc Business Overview
7.2.3 GlaxoSmithKline plc Antibodies in Oncology Major Product Offerings
7.2.4 GlaxoSmithKline plc Antibodies in Oncology Revenue in Global (2016-2021)
7.2.5 GlaxoSmithKline plc Key News
7.3 Biogen Idec Inc.
7.3.1 Biogen Idec Inc. Corporate Summary
7.3.2 Biogen Idec Inc. Business Overview
7.3.3 Biogen Idec Inc. Antibodies in Oncology Major Product Offerings
7.3.4 Biogen Idec Inc. Antibodies in Oncology Revenue in Global (2016-2021)
7.3.5 Biogen Idec Inc. Key News
7.4 Bristol Myers Squibb Co.
7.4.1 Bristol Myers Squibb Co. Corporate Summary
7.4.2 Bristol Myers Squibb Co. Business Overview
7.4.3 Bristol Myers Squibb Co. Antibodies in Oncology Major Product Offerings
7.4.4 Bristol Myers Squibb Co. Antibodies in Oncology Revenue in Global (2016-2021)
7.4.5 Bristol Myers Squibb Co. Key News
7.5 AstraZeneca plc.
7.5.1 AstraZeneca plc. Corporate Summary
7.5.2 AstraZeneca plc. Business Overview
7.5.3 AstraZeneca plc. Antibodies in Oncology Major Product Offerings
7.5.4 AstraZeneca plc. Antibodies in Oncology Revenue in Global (2016-2021)
7.5.5 AstraZeneca plc. Key News
7.6 Celltrion
7.6.1 Celltrion Corporate Summary
7.6.2 Celltrion Business Overview
7.6.3 Celltrion Antibodies in Oncology Major Product Offerings
7.6.4 Celltrion Antibodies in Oncology Revenue in Global (2016-2021)
7.6.5 Celltrion Key News
7.7 3SBIO
7.7.1 3SBIO Corporate Summary
7.7.2 3SBIO Business Overview
7.7.3 3SBIO Antibodies in Oncology Major Product Offerings
7.4.4 3SBIO Antibodies in Oncology Revenue in Global (2016-2021)
7.7.5 3SBIO Key News
7.8 Celgen Biopharma
7.8.1 Celgen Biopharma Corporate Summary
7.8.2 Celgen Biopharma Business Overview
7.8.3 Celgen Biopharma Antibodies in Oncology Major Product Offerings
7.8.4 Celgen Biopharma Antibodies in Oncology Revenue in Global (2016-2021)
7.8.5 Celgen Biopharma Key News
7.9 Dr Reddy’s
7.9.1 Dr Reddy’s Corporate Summary
7.9.2 Dr Reddy’s Business Overview
7.9.3 Dr Reddy’s Antibodies in Oncology Major Product Offerings
7.9.4 Dr Reddy’s Antibodies in Oncology Revenue in Global (2016-2021)
7.9.5 Dr Reddy’s Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables and Figures
Ask Sample Report to get more details… NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com